
Transporter pharmacology & small molecule discovery
Small molecules that tune transporter activity, stability and trafficking to address disease mechanisms.
Show detailsHide details about Transporter pharmacology & small molecule discovery
A central pillar of our lab is the precise pharmacological modulation of membrane transporters. We deploy diverse chemical strategies, ranging from intrasteric inhibitors and PROTAC-mediated targeted protein degradation, to chaperones and pharmacological correctors to enhance transporter folding, trafficking, stability or activity. By matching targeted small molecules to specific disease mechanisms, particularly in rare genetic disorders, we aim to build a comprehensive pharmacological toolkit to therapeutically reprogram transporter function across distinct metabolic contexts.

Hypusine–eIF5A modulation
Reprogramming mitochondrial function through hypusination-dependent translation.
Show detailsHide details about Hypusine–eIF5A modulation
We investigate how mitochondrial activity is dynamically tuned to the metabolic state of a cell. In particular, we are interested in regulation of the hypusine–eIF5A pathway and are working on its pharmacological modulation. By altering hypusination-dependent translational programmes, we aim to reprogram mitochondrial function, metabolic capacity and transporter-dependent metabolic states. Crucially, we test the role of this pathway in diseases linked to altered or deficient mitochondrial output, including certain forms of Parkinson’s Disease and mitochondrial disorders.

Human CNS models and organoids
Human neural cultures and organoids to connect metabolism, development and CNS disease.
Show detailsHide details about Human CNS models and organoids
We deploy human CNS platforms, ranging from 2D neural cultures to 3D cerebral organoids and regional assembloids, to dissect complex disease mechanisms within a physiologically relevant yet experimentally tractable human context. These systems enable high-precision biochemical, metabolic, genetic, and pharmacological perturbations across distinct neural cell types and interconnected brain regions. By mapping the differential metabolic and mitochondrial requirements of human brain development, we uncover how metabolic dysregulation drives cell fate defects and circuit dysfunction across a spectrum of CNS disorders.

AI-Driven metabolism & neural fate mapping
Linking single-cell data, metabolic programmes and neural circuit function.
Show detailsHide details about AI-Driven metabolism & neural fate mapping
Neural progenitor fate decisions, cell identities, and functional circuit maturation are actively instructed by membrane transporter activity, solute fluxes, and mitochondrial metabolic programs. Combining machine learning with single-cell multi-omics, spatial metabolomics, and HD-MEA electrophysiology allows our computational models to work hand-in-hand with experimental 2D and 3D organoid systems. In neurodevelopmental and neurodegenerative disorders, where metabolic failure precedes structural loss, this integrative framework links transporter dysfunction to altered neural firing, identifying druggable targets to pharmacologically reprogram diseased neural states.

Functional genomics & CRISPR perturbations
Genetic screens and precise editing to reveal causal regulators of cell function.
Show detailsHide details about Functional genomics & CRISPR perturbations
We apply genome-wide, metabolome-wide, and transportome-wide CRISPR screens in both loss-of-function and gain-of-function modes to uncover genetic modifiers of cellular differentiation and metabolic state. In parallel, targeted genome editing allows us to engineer and correct disease-associated variants, precisely manipulate transporters and metabolic regulators, and map essential regulatory dependencies. This integrative approach enables us to draw direct causal links connecting genotype, molecular mechanism, metabolic phenotype, and cellular function.

Computational systems biology & predictive AI
Integrating multi-omics to predict metabolic states and prioritise intervention points.
Show detailsHide details about Computational systems biology & predictive AI
We integrate multi-modal transcriptomic, epigenomic, proteomic, spatial metabolomic, and population-scale genomic data to reconstruct the multi-layered regulomes governing transporter expression and activity. We aim at building predictive computational models of cellular metabolic states that link metabolic feedback loops to mitochondrial function and cell identity. These high-dimensional models allow us to map dynamic cell-state transitions, predict disease trajectories, and prioritize druggable nodes for targeted genetic or pharmacological intervention.

RESOLUTE and systematic transporter biology
Transporter models, interaction maps and metabolomics for systematic discovery.
Show detailsHide details about RESOLUTE and systematic transporter biology
We will continue to exploit and extend the resources generated by the RESOLUTE project, both to pursue emerging mechanistic insights and to extract new biology from its unique collections of genetically-defined transporter models. For this, we pursue two complementary strategies: targeted mechanistic findings (e.g.: characterising physical interaction of SLC transporters with metabolic enzymes) and large-scale mapping to define protein-protein interaction archetypes within the membrane domain.
To systematically connect individual transporters to cellular metabolism, we perform untargeted metabolomics of isogenic knock out cell lines in the RESOLUTE collection. These highly controlled systems provide a powerful framework to identify transporter substrates, map metabolic consequences and functional dependencies, and uncover how transmembrane solute exchange shapes broader cellular networks.
